Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 412-418

  Czarny, Piotr ^a   Kwiatkowski, Dominik ^a   Kacperska, Dagmara ^a   Kawczyńska, Daria ^a   Talarowska, Monika ^b   Orzechowska, Agata ^b   Bielecka Kowalska, Anna ^c   Szemraj, Janusz ^b   Gałecki, Piotr ^b   Śliwiński, Tomasz ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Non public Medical Center Akoria   (Poland)

Author keywords

Depression; DNA damage; DNA repair; Oxidative stress; Reactive oxygen species

Indexed keywords

DNA GLYCOSYLTRANSFERASE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; CELL ISOLATION; COMET ASSAY; CONTROLLED STUDY; DEPRESSION; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ELECTROPHORESIS; EXCISION REPAIR; FLUORESCENCE MICROSCOPY; HUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; SINGLE STRANDED DNA BREAK; STRESS; GENETICS; MIDDLE AGED; MONONUCLEAR CELL; NONPARAMETRIC TEST; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLAND; RECURRENT DISEASE;

ADULT; COMET ASSAY; DEPRESSIVE DISORDER; DNA DAMAGE; DNA REPAIR; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; OXIDATION-REDUCTION; POLAND; RECURRENCE; STATISTICS, NONPARAMETRIC;

EID: 84922374295     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892317     Document Type: Article

References (39)

1. http://www.who.int/mediacentre/factsheets/fs369/en/, October 2012
2. Greden JF: The burden of disease for treatment-resistant depression. J Clin Psychiatry, 2001; 62(Suppl.16): 26–31
3. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet, 1997; 349: 1498–504
4. Zheng Z, Zeng Y, Huang H et al: MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: A hypothesis. Med Sci Monit, 2013; 19: 438–43
5. Iwata M, Ota KT, Duman RS: The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun, 2013; 31: 105–14
6. Patel A: Review: the role of inflammation in depression. Psychiatr Danub, 2013; 25(Suppl.2): S216–23
7. Gardner A Boles RG: Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry, 2011; 35(3): 730–43
8. Maes M, Bosmans E, Meltzer HY et al: Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry, 1993; 150(8): 1189–93
9. Rawdin BJ, Mellon SH, Dhabhar FS et al: Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun, 2013; 31: 143–52
10. Alcocer-Gómez E, de Miguel M, Casas-Barquero N et al: NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun, 2014; 36: 111–17
11. Müller N, Schwarz MJ, Dehning S et al: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a doubleblind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry, 2006; 11(7): 680–84
12. Nery FG, Monkul ES, Hatch JP et al: Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol, 2008; 23(2): 87–94
13. Hannestad J, DellaGioia N, Bloch M: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a metaanalysis. Neuropsychopharmacology, 2011; 36(12): 2452–59
14. Abbasi SHl, Hosseini F, Modabbernia A et al: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebocontrolled study. J Affect Disord, 2012; 141(2–3): 308–14
15. Leemans JC, Cassel SL, Sutterwala FS: Sensing damage by the NLRP3 inflammasome. Immunol Rev, 2011; 243(1): 152–62
16. Zhou R, Yazdi AS, Menu P et al: A role for mitochondria in NLRP3 inflammasome activation. Nature, 2011; 469(7329): 221–25
17. Licandro G, Ling Khor H, Beretta O et al: The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells. Eur J Immunol, 2013; 43(8): 2126–37
18. Forlenza MJ, Miller GE: Increased serum levels of 8-hydroxy-2’-deoxyguanosine in clinical depression. Psychosom Med, 2006; 68(1): 1–7
19. Wei YC, Zhou FL, He DL et al: Oxidative stress in depressive patients with gastric adenocarcinoma. Int J Neuropsychopharmacol, 2009; 12(8): 1089–96
20. Kupper N, Gidron Y, Winter J et al: Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med, 2009; 71(9): 973–80
21. Maes ML, Mihaylova I, Kubera M et al: Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett, 2009; 30(6): 715–22
22. Irie M, Asami S, Ikeda M et al: Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun, 2003; 311(4): 1014–18
23. Irie M, Asami S, Nagata S et al: Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res, 2001; 92(3): 367–76
24. Yi S, Nanri A, Matsushita Y et al: Depressive symptoms and oxidative DNA damage in Japanese municipal employees. Psychiatry Res, 2012; 200(2–3): 318–22
25. ICD-10 Classification of Mental&Behavioural Disorders. Geneva: World Health Organization, 1993
26. Patten S: Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can, 1997; 3: 18–24
27. Singh NP, McCoy MT, Tice RR et al: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 1988; 175: 184–91
28. Klaude M, Eriksson S, Nygren J et al: The comet assay: mechanisms and technical considerations. Mutat Res, 1996; 12: 89–96
29. Blasiak J, Gloc E, Drzewoski J et al: Free radicals scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat Res, 2003; 535: 25–34
30. Blasiak J, Synowiec E, Tarnawska J et al: Dental methacrylates may exert genotoxic effects via the oxidative induction of DNA double strand breaks and the inhibition of their repair. Mol Biol Rep, 2012; 39: 7487–96
31. Bjorâs M, Luna L, Johnsen B et al: Opposite base-dependent reactions of a human base excision repair enzyme on DNA containing 7, 8-dihydro-8-oxoguanine and abasic sites. EMBO J, 1997; 16: 6314–22
32. Boiteux S, Radicella J: Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie, 1999; 81: 59–67
33. Dizdaroglu M, Laval J, Boiteux S: Substrate specificity of the Escherichia coli endonuclease III: excision of thymine- and cytosine-derived lesions in DNA produced by radiation-generated free radicals. Biochemistry, 1993; 32: 12105–11
34. Hatahet Z, Kow YW, Purmal AA et al: New substrates for old enzymes. 5-Hydroxy-2’-deoxycytidine and 5-hydroxy-2’-deoxyuridine are substrates for Escherichia coli endonuclease III and formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2’-deoxyuridine is a substrate for uracil DNA N-glycosylase. J Biol Chem, 1994; 269: 18814–20
35. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27(1): 24-31.
36. Memon RA, Staprans I, Noor M et al: Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol, 2000; 20: 1536–42
37. Aust AE, Eveleigh JF: Mechanisms of DNA oxidation. Proc Soc Exp Biol Med, 1999; 222: 246–52
38. Yager S, Forlenza MJ, Miller GE: Depression and oxidative damage to lipids. Psychoneuroendocrinology. 2010; 35: 1356–62
39. Boesch P, Weber-Lotfi F, Ibrahim N et al: DNA repair in organelles: Pathways, organization, regulation, relevance in disease and aging. Biochim Biophys Acta, 2011; 1813(1): 186–200